Rynek i konsumenci · 20/11/1996
FDA Proposes Rule for Child-Resistant Packaging of Ketoprofen Preparations
The FDA is proposing a rule to require child-resistant packaging for ketoprofen preparations containing more than 50 mg of ketoprofen per retail package, aiming to protect children under 5 years of age from potential harm.
Source: Federal Register — Consumer Product Safety CommissionOpen original release →